Table 3 Hormone receptors and HER2 results in ductal carcinoma in situ (DCIS) and invasive carcinoma.
From: Histopathologic features of breast cancer in Li–Fraumeni syndrome
ER+/HER2+ | ER+/HER2− | ER−/HER2+ | ER−/HER2− | Total | |
---|---|---|---|---|---|
DCIS | 2 | 2 | 4 | 0 | 8 |
Invasive carcinoma | 9 | 7 | 0 | 1 | 17 |
Total | 11 (44%) | 9 (36%) | 4 (16%) | 1 (4%) | 25 |